Imbio PHA (4.0.0) vs CT Cardiomegaly
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA if your primary need is to rapidly assess right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension from CT pulmonary angiogram (CTPA) scans. This tool is ideal for clinical workflows requiring automated measurements of specific cardiac structures like RV/LV and PA/Ao ratios, providing annotated DICOM images and summary reports for critical decision-making.
View Imbio PHA (4.0.0) →Choose CT Cardiomegaly if…
Choose Innolitics' CT Cardiomegaly if your objective is to quantitatively detect general cardiomegaly by automatically measuring the cardiothoracic ratio from standard CT chest images. This command-line software is well-suited for integration into existing automated pipelines or research environments where a robust, machine learning-driven tool is needed to provide both linear and area-based cardiothoracic ratios in PDF and JSON formats.
View CT Cardiomegaly →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | CT Cardiomegaly |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Docker Container (Ubuntu 20.04), command-line software |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA is designed for seamless integration into existing clinical workflows, generating annotated DICOM images and PDF reports, and offering flexible deployment options (Cloud, Enterprise, partners). In contrast, Innolitics' CT Cardiomegaly is a command-line software tool deployed as a Docker container, suggesting a more technical interface that may require greater IT expertise for typical clinical users.
Clinical Value
Imbio PHA (4.0.0)Imbio PHA provides automated measurements of complex cardiac structures (RV/LV and PA/Ao ratios) from CTPA scans, directly aiding in the diagnosis and risk stratification of critical conditions like pulmonary embolism and hypertension. While CT Cardiomegaly offers quantitative cardiothoracic ratio measurements for cardiomegaly detection, Imbio PHA's application addresses a more specific and high-acuity diagnostic pathway.
Pricing & Value
TieBoth Imbio PHA and Innolitics CT Cardiomegaly explicitly state 'contact for pricing' in their specifications. No public pricing information or transparent pricing models were found for either product through web searches, making a direct comparison of their pricing and value impossible.
Enterprise Readiness
Imbio PHA (4.0.0)Both tools are FDA-cleared and HIPAA compliant, essential for enterprise use. However, Imbio PHA offers more versatile deployment options (Cloud, Enterprise on-premise, or via partners) and boasts third-party HIPAA certification, indicating a more robust and adaptable solution for diverse enterprise IT environments. Innolitics' Docker container and command-line deployment might present more integration challenges for large organizations.
Innovation
Imbio PHA (4.0.0)Both tools utilize AI for medical image analysis. Imbio PHA's focus on detailed, multi-structural cardiac measurements and ratios for the diagnosis and risk stratification of pulmonary embolism and hypertension represents a more specialized and clinically advanced application of AI. Imbio also demonstrates a broader portfolio of AI algorithms in cardiothoracic imaging, suggesting a deeper innovative pipeline.
Support & Docs
Imbio PHA (4.0.0)Imbio PHA provides clear and accessible support channels, including phone numbers (U.S. and India), email support, and an online case submission form with specified support hours, and explicitly mentions requesting user manuals. While Innolitics is a software development firm, explicit product-specific support and documentation details for CT Cardiomegaly are not as clearly outlined in the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | CT Cardiomegaly |
|---|---|---|
| Name | Imbio PHA (4.0.0) | CT Cardiomegaly |
| Company | Imbio | Innolitics |
| Primary Clinical Focus | Assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | Assisting physicians in cardiomegaly detection with quantitative data. |
| Key Measurements/Ratios | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios. | Automatic cardiothoracic ratio measurement; Calculates linear and area-based cardiothoracic ratios. |
| Output Formats | Annotated DICOM images, PDF summary reports | PDF and JSON reports |
| AI/ML Technology/Framework | Utilizes artificial intelligence algorithms for anatomical identification and measurement | Machine learning algorithms for segmentation; Non-adaptive machine learning using MONAI framework |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and CT Cardiomegaly.